Strategies to manage hepatitis C virus infection disease burden-Volume 4

Chen DS 1 , Hamoudi W 2 , Mustapha B 3 , Layden J 4 , Nersesov A 5 , Reic T 6 Show all authors , Garcia V 7 , Rios C 8 , Mateva L 9 , Njoya O 10 , Al-Busafi SA 11 , Abdelmageed MK 12 , Abdulla M 13 , Adda D 14 , Akin O 15 , Al Baqali A 16 , Al Dweik N 17 , Al Ejji K 17 , Al Ghazzawi I 18 , Al Kaabi S 17 , Al Naamani K 19 , Al Qamish J 20 , Al Sadadi M 13 , Al Salman J 13 , AlBadri M 17 , Al-Romaihi HE 21 , Ampofo W 22 , Antonov K 9 , Anyaike C 15 , Arome F 23 , Bane A 24 , Blach S 25 , Borodo MM 26 , Brandon SM 25 , Bright B 27 , Butt MT 17 , Cardenas I 28 , Chan HLY 29 , Chen CJ 30 , Chen PJ 31 , Chien RN 32 , Chuang WL 33 , Cuellar D 34 , Derbala M 17 , Elbardiny AA 21 , Estes C 25 , Farag E 21 , Fung J 35 , Gamkrelidze I 25 , Genov J 36 , Ghandour Z 37 , Ghuloom M 13 , Gomez B 38 , Gunter J 25 , Habeeb J 13 , Hajelssedig O 17 , Himatt SM 21 , Hrstic I 39 , Hu CC 32 , Huang CF 33 , Hui YT 40 , Jahis R 41 , Jelev D 9 , John AK 17 , Kaliaskarova KS 42 , Kamel Y 17 , Kao JH 43 , Khamis J 13 , Khattabi H 44 , Khoudri I 45 , Konysbekova A 46 , Kotzev I 47 , Lai MS 48 , Lao WC 49 , Lee MH 50 , Lesi O 51 , Li M 52 , Lo A 53 , Loo CK 54 , Lukšić B 55 , Maaroufi A 45 , Malu AO 56 , Mitova R 36 , Mohamed R 57 , Morović M 58 , Murphy K 25 , Nde H 25 , Ngige E 15 , Njouom R 59 , Nonković D 60 , Obekpa S 23 , Oguche S 61 , Okolo EE 62 , Omede O 15 , Omuemu C 63 , Ondoa P 64 , Opare-Sem O 65 , Owusu-Ofori S 66 , Phillips RO 65 , Prokopenko YN 67 , Razavi H 25 , Razavi-Shearer D 25 , Razavi-Shearer K 25 , Redae B 68 , Rinke de Wit T 69 , Robbins S 25 , Roberts LR 70 , Sanad SJ 37 , Sharma M 17 , Simonova M 71 , Su TH 43 , Sultan K 17 , Tan SS 72 , Tchernev K 73 , Tsang OTY 74 , Tsang S 75 , Tzeuton C 76 , Ugoeze S 77 , Uzochukwu B 78 , Vi R 67 , Vince A 79 , Wani HU 17 , Wong VWS 29 , Workneh A 80 , Yacoub R 17 , Yesmembetov KI 81 , Youbi M 45 , Yuen MF 82 , Schmelzer JD 25

Affiliations 

  • 1 Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan
  • 2 Department of Gastroenterology & Hepatology, Al Bashir Hospital, Amman, Jordan
  • 3 IBN SINA Hospital, Rabat, Morocco
  • 4 Department of Public Health Sciences, Loyola University Chicago, Chicago, IL, USA
  • 5 National Research Institute of Cardiology and Internal Diseases, Almaty, Kazakhstan
  • 6 European Liver Patients Association, Sint-Truiden, Belgium
  • 7 Ministry of Public Health, Santo Domingo, Dominican Republic
  • 8 Department of Health Promotion and Disease Prevention, Ministry of Health and Social Protection, Bogota, Colombia
  • 9 University Hospital "St. Ivan Rilski", Sofia, Bulgaria
  • 10 Research Laboratory on Viral Hepatitis & Health Communication, Faculty of Medicine, University of Yaoundé, Yaoundé, Cameroon
  • 11 Division of Gastroenterology, Department of Medicine, Sultan Qaboos University Hospital, Muscat, Oman
  • 12 Hamad Medical Corporation, Doha, Qatar
  • 13 Salmaniya Medical Complex, Manama, Bahrain
  • 14 Civil Society Network on Hepatitis, Abuja, Nigeria
  • 15 Federal Ministry of Health, Abuja, Nigeria
  • 16 Al Kindi Specialised Hospital, Manama, Bahrain
  • 17 Division of Gastroenterology, Department of Medicine, Hamad Medical Corporation, Doha, Qatar
  • 18 GI and Hepatology Department, Jordan Royal Medical Services, Amman, Jordan
  • 19 Division of Gastroenterology and Hepatology, Department of Medicine, Armed Forces Hospital, Muscat, Oman
  • 20 Gastroenterolgy Clinic, IBN Al-Nafees Hospital, Manama, Bahrain
  • 21 Ministry of Public Health Qatar, Doha, Qatar
  • 22 Noguchi Memorial Institute for Medical Research, University of Ghana, Legon, Ghana
  • 23 Advocacy for the Prevention of Hepatitis in Nigeria, Jos, Nigeria
  • 24 Gastroenterology and Hepatology, Addis Ababa University Medical School, Addis Ababa, Ethiopia
  • 25 Center for Disease Analysis (CDA), Lafayette, CO, USA
  • 26 Aminu Kano Teaching Hospital, Kano, Nigeria
  • 27 LiveWell Initiative (LWI), Lagos, Nigeria
  • 28 Communicable Diseases Division, Ministry of Health and Social Protection, Bogota, Colombia
  • 29 Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong, China
  • 30 Academia Sinica, Taipei, Taiwan
  • 31 National Taiwan University, Taipei, Taiwan
  • 32 Liver Research Unit, Keelung Chang Gung Memorial Hospital, Keelung, Taiwan
  • 33 Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung City, Taiwan
  • 34 Department of Epidemiology and Demography, Ministry of Health and Social Protection, Bogota, Colombia
  • 35 Department of Medicine, The University of Hong Kong, Hong Kong, China
  • 36 University Hospital "Queen Joanna", Sofia, Bulgaria
  • 37 BDF Hospital, Royal Medical Services, Riffa, Bahrain
  • 38 Pan American Health Organization, Washington, DC, USA
  • 39 General Hospital Pula, Pula, Croatia
  • 40 Department of Medicine, Queen Elizabeth Hospital, Hong Kong, China
  • 41 Disease Control Division, Ministry of Health, Putrajaya, Malaysia
  • 42 Ministry of Healthcare and Social Development of the Republic of Kazakhstan, Astana, Kazakhstan
  • 43 Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan
  • 44 Eastern Mediterranean Regional Office, World Health Organization, Cairo, Egypt
  • 45 Department of Epidemiology and Disease Control, Ministry of Health, Rabat, Morocco
  • 46 Republican Diagnostic Center, Astana, Kazakhstan
  • 47 University Hospital "St. Marina", Varna, Bulgaria
  • 48 Department of Medicine, North District Hospital, Hong Kong, China
  • 49 Department of Medicine, Pamela Youde Nethersole Eastern Hospital, Hong Kong, China
  • 50 Institute of Clinical Medicine, National Yang-Ming University, Taipei, Taiwan
  • 51 University of Lagos, Lagos, Nigeria
  • 52 Division of Gastroenterology and Hepatology, Department of Medicine and Geriatrics, Tuen Mun Hospital, Hong Kong, China
  • 53 Institute of Digestive Disease, The Chinese University of Hong Kong, Hong Kong, China
  • 54 Department of Medicine and Geriatrics, Kwong Wah Hospital, Hong Kong, China
  • 55 Clinical Department of Infectious Diseases, Split University Hospital and Split University Medical School, Split, Croatia
  • 56 Benue State University Teaching Hospital, Makurdi, Nigeria
  • 57 University of Malaya Medical Centre, Kuala Lumpur, Malaysia
  • 58 Department of Infectious Diseases, Zadar General Hospital, Zadar, Croatia
  • 59 Virology Department, Centre Pasteur of Cameroon, Yaounde, Cameroon
  • 60 Department of Epidemiology, Institute of Public Health, Split, Croatia
  • 61 Department of Pediatrics, University of Jos, Jos, Nigeria
  • 62 Beacon Youth Initiative, Lafia, Nigeria
  • 63 University of Benin, Benin City, Nigeria
  • 64 Amsterdam Institute for Global Health and Development, Amsterdam, The Netherlands
  • 65 Kwame Nkrumah University of Science and Technology, Kumasi, Ghana
  • 66 Komfo Anokye Teaching Hospital, Kumasi, Ghana
  • 67 Republican Coordination Center for Hepatology and Gastroenterology, Astana, Kazakhstan
  • 68 Ethiopian Gastroenterological Association, Addis Ababa, Ethiopia
  • 69 PharmAccess Foundation, Department of Global Health, University of Amsterdam, Amsterdam, The Netherlands
  • 70 Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, USA
  • 71 Clinic of Gastroenterology, Military Medical Academy, Sofia, Bulgaria
  • 72 Department of Hepatology, Selayang Hospital, Selangor, Malaysia
  • 73 "Sofiamed" Hospital, Sofia, Bulgaria
  • 74 Department of Medicine and Geriatrics, Princess Margaret Hospital Authority, Hong Kong, SAR China
  • 75 Department of Medicine, Tseung Kwan O Hospital, Hong Kong, China
  • 76 Faculty of Medicine and Pharmaceutical Sciences, University of Douala, Douala, Cameroon
  • 77 Federal Medical Centre, Jalingo, Nigeria
  • 78 Institute of Public Health, University of Nigeria, Nsukka, Nigeria
  • 79 Medical School University of Zagreb, University Hospital of Infectious Diseases Zagreb, Zagreb, Croatia
  • 80 Non-Communicable Diseases Programme, World Health Organization, Addis Ababa, Ethiopia
  • 81 National Scientific Center of Oncology and Transplantation, Astana, Kazakhstan
  • 82 Department of Medicine, Queen Mary Hospital, The University of Hong Kong, Hong Kong, China
J Viral Hepat, 2017 10;24 Suppl 2:44-63.
PMID: 29105286 DOI: 10.1111/jvh.12759

Abstract

The hepatitis C virus (HCV) epidemic was forecasted through 2030 for 17 countries in Africa, Asia, Europe, Latin America and the Middle East, and interventions for achieving the Global Health Sector Strategy on viral hepatitis targets-"WHO Targets" (65% reduction in HCV-related deaths, 90% reduction in new infections and 90% of infections diagnosed by 2030) were considered. Scaling up treatment and diagnosis rates over time would be required to achieve these targets in all but one country, even with the introduction of high SVR therapies. The scenarios developed to achieve the WHO Targets in all countries studied assumed the implementation of national policies to prevent new infections and to diagnose current infections through screening.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

MeSH terms
Similar publications